The role of steroid receptor coactivator-3 (SRC-3) in human malignant disease

European Journal of Surgical Oncology

Volumn 36, Issue 3, 2010, Pages 224-229

  Gojis, O ^a,b   Rudraraju, B ^b   Alifrangis, C ^b   Krell, J ^b   Libalova, P ^a   Palmieri, C ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

AIB1; Human; Malignant disease; SRC 3

Indexed keywords

STEROID RECEPTOR COACTIVATOR 3; TUMOR MARKER;

CANCER RISK; CARCINOGENESIS; COLORECTAL CANCER; DIAGNOSTIC VALUE; ENDOMETRIUM CARCINOMA; HUMAN; LIVER CELL CARCINOMA; MENINGIOMA; NASOPHARYNX CARCINOMA; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; STOMACH CANCER; URINARY TRACT CANCER;

ANIMALS; DNA, PLANT; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; NUCLEAR RECEPTOR COACTIVATOR 3; PROGNOSIS; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 76449110836     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2009.08.002     Document Type: Review

References (30)

1. McKenna N.J., and O'Malley B.W. Minireview: nuclear receptor coactivators - an update. Endocrinology 143 (2002) 2461-2465
2. Mussi P., Yu C., O'Malley B.W., et al. Stimulation of steroid receptor coactivator-3 (SRC-3) gene overexpression by a positive regulatory loop of E2F1 and SRC-3. Mol Endocrinol 20 (2006) 3105-3119
3. Wu R.C., Qin J., Yi P., et al. Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic responses to multiple cellular signaling pathways. Mol Cell 15 (2004) 937-949
4. Torres-Arzayus M.I., Font de Mora J., Yuan J., et al. High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene. Cancer Cell 6 (2004) 263-274
5. Xu J., Liao L., Ning G., et al. The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc Natl Acad Sci U S A 97 (2000) 6379-6384
6. Gnanapragasam V.J., Leung H.Y., Pulimood A.S., et al. Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer. Br J Cancer 85 (2001) 1928-1936
7. Zhou H.J., Yan J., Luo W., et al. SRC-3 is required for prostate cancer cell proliferation and survival. Cancer Res 65 (2005) 7976-7983
8. Glaeser M., Floetotto T., Hanstein B., et al. Gene amplification and expression of the steroid receptor coactivator SRC3 (AIB1) in sporadic breast and endometrial carcinomas. Horm Metab Res 33 (2001) 121-126
9. Kershah S.M., Desouki M.M., Koterba K.L., et al. Expression of estrogen receptor coregulators in normal and malignant human endometrium. Gynecol Oncol 92 (2004) 304-313
10. Sakaguchi H., Fujimoto J., Sun W.S., et al. Clinical implications of steroid receptor coactivator (SRC)-3 in uterine endometrial cancers. J Steroid Biochem Mol Biol 104 (2007) 237-240
11. Balmer N.N., Richer J.K., Spoelstra N.S., et al. Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: correlation with clinicopathologic parameters and biomarkers. Mod Pathol 19 (2006) 1593-1605
12. Fujita Y., Sakakura C., Shimomura K., et al. Chromosome arm 20q gains and other genomic alterations in esophageal squamous cell carcinoma, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization. Hepatogastroenterology 50 (2003) 1857-1863
13. Xu F.P., Xie D., Wen J.M., et al. SRC-3/AIB1 protein and gene amplification levels in human esophageal squamous cell carcinomas. Cancer Lett 245 (2007) 69-74
14. Al-azawi D., Ilroy M.M., Kelly G., et al. Ets-2 and p160 proteins collaborate to regulate c-Myc inendocrine resistant breast cancer. Oncogene 27 (2008) 3021-3031
15. Qin L., Liao L., Redmond A., et al. The AIB1 oncogene promotes breast cancer metastasis by activation of PEA3-mediated matrix metalloproteinase 2 (MMP2) and MMP9 expression. Mol Cell Biol 28 (2008) 5937-5950
16. Sakakura C., Hagiwara A., Yasuoka R., et al. Amplification and over-expression of the AIB1 nuclear receptor co-activator gene in primary gastric cancers. Int J Cancer 89 (2000) 217-223
17. Xie D., Sham J.S., Zeng W.F., et al. Correlation of AIB1 overexpression with advanced clinical stage of human colorectal carcinoma. Hum Pathol 36 (2005) 777-783
18. Henke R.T., Haddad B.R., Kim S.E., et al. Overexpression of the nuclear receptor coactivator AIB1 (SRC-3) during progression of pancreatic adenocarcinoma. Clin Cancer Res 10 (2004) 6134-6142
19. Wang Y., Wu M.C., Sham J.S., et al. Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray. Cancer 95 (2002) 2346-2352
20. Luo J.H., Xie D., Liu M.Z., et al. Protein expression and amplification of AIB1 in human urothelial carcinoma of the bladder and overexpression of AIB1 is a new independent prognostic marker of patient survival. Int Cancer 122 (2008) 2554-2561
21. Liu M.Z., Xie D., Mai S.J., et al. Overexpression of AIB1 in nasopharyngeal carcinomas correlates closely with advanced tumor stage. Am J Clin Pathol 129 (2008) 728-734
22. Carroll R.S., Brown M., Zhang J., et al. Expression of a subset of steroid receptor cofactors is associated with progesterone receptor expression in meningiomas. Clin Cancer Res 6 (2000) 3570-3575
23. Shirazi S.K., Bober M.A., and Coetzee G.A. Polymorphic exonic CAG microsatellites in the gene amplified in breast cancer (AIB1 gene). Clin Genet 54 (1998) 102-103
24. Chamberlain N.L., Driver E.D., and Miesfeld R.L. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 22 (1994) 3183-3186
25. Hsing A.W., Chokkalingam A.P., Gao Y.T., et al. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 11 (2002) 337-341
26. Platz E.A., Giovannucci E., Brown M., et al. Amplified in breast cancer-1 glutamine repeat and prostate cancer risk. Prostate J 2 (2000) 27-32
27. Li A.J., Lerner D.L., Gapuzan M.E., et al. AIB1 polymorphisms predict aggressive ovarian cancer phenotype. Cancer Epidemiol Biomarkers Prev 14 (2005) 2919-2922
28. Harigopal M., Heymann J., Ghosh S., et al. Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome. Breast Cancer Res Treat 155 (2009) 77-85
29. Liao L., Chen X., Wang S., et al. Steroid receptor coactivator 3 maintains circulating insulin-like growth factor I (IGF-I) by controlling IGF-binding protein 3 expression. Mol Cell Biol 28 (2008) 2460-2469
30. Oh A., List H.J., Reiter R., et al. The nuclear receptor coactivator AIB1 mediates insulin-like growth factor I-induced phenotypic changes in human breast cancer cells. Cancer Res 64 (2004) 8299-8308